An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
AtriCure, Inc. (ATRC) will be participating in the 2024 Bank of America Securities Healthcare Conference. The company is known for its innovative surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management. The management will present on May 14, 2024, at 10:15 a.m. PDT.
AtriCure, Inc. (ATRC) parteciperà alla Conferenza Sanitaria di Bank of America Securities nel 2024. L'azienda è nota per i suoi trattamenti chirurgici innovativi per la fibrillazione atriale, la gestione dell'auricola sinistra e il controllo del dolore post-operatorio. La direzione presenterà il 14 maggio 2024 alle 10:15 PDT.
AtriCure, Inc. (ATRC) participará en la Conferencia de Salud de Bank of America Securities en 2024. La compañía es conocida por sus tratamientos quirúrgicos innovadores para la fibrilación auricular, la gestión de la aurícula izquierda y el manejo del dolor postoperatorio. La dirección presentará el 14 de mayo de 2024 a las 10:15 a.m. PDT.
AtriCure, Inc. (ATRC)는 2024년 Bank of America Securities 헬스케어 컨퍼런스에 참가할 예정입니다. 이 회사는 심방세동, 좌심방 충수 관리, 그리고 수술 후 통증 관리를 위한 혁신적인 외과적 치료로 잘 알려져 있습니다. 경영진은 2024년 5월 14일 오전 10시 15분 PDT에 발표할 예정입니다.
AtriCure, Inc. (ATRC) participera à la Conférence sur la Santé des Valeurs Mobilières de Bank of America en 2024. L'entreprise est reconnue pour ses traitements chirurgicaux innovants pour la fibrillation auriculaire, la gestion de l'appendice auriculaire gauche et la gestion de la douleur post-opératoire. La direction présentera le 14 mai 2024 à 10h15 PDT.
AtriCure, Inc. (ATRC) wird an der Bank of America Securities Gesundheitskonferenz 2024 teilnehmen. Das Unternehmen ist bekannt für seine innovativen chirurgischen Behandlungen bei Vorhofflimmern, Management des linken Vorhofohrs und Nachschmerzmanagement. Das Management wird am 14. Mai 2024 um 10:15 Uhr PDT präsentieren.
Positive
None.
Negative
None.
MASON, Ohio--(BUSINESS WIRE)--
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Bank of America Securities Healthcare Conference.
AtriCure’s management is scheduled to present on Tuesday, May 14, 2024, at 10:15 a.m. Pacific Daylight Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
When will AtriCure be participating in the Bank of America Securities Healthcare Conference?
AtriCure will be participating on Tuesday, May 14, 2024, at 10:15 a.m. Pacific Daylight Time.
What is AtriCure known for?
AtriCure is known for its innovative surgical treatments and therapies for atrial fibrillation, left atrial appendage management, and post-operative pain management.
Where can interested parties access the live audio webcast of the conference?
Interested parties can access the live audio webcast by visiting the 'Investors' section of AtriCure's website at https://ir.atricure.com.
atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
